Due to numerous mutations in the spike protein, the SARS-CoV-2 variant of concern
Omicron (B.1.1.529) raises serious concerns since it may significantly limit the antibody-mediated …

Omicron is the evolutionarily most distinct severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
variant of concern (VOC) to date. We report that Omicron BA.1 breakthrough …

Background In recent months, Omicron variants of SARS-CoV-2 have become dominant in
many regions of the world, and case numbers with Omicron subvariants BA.1 and BA.2 …

The capacity of convalescent and vaccine-elicited sera and monoclonal antibodies (mAb) to
neutralize SARS-CoV-2 variants is currently of high relevance to assess the protection …

This case series assessed a commercial airline flight from Tel Aviv, Israel, to Frankfurt, Germany,
that occurred on March 9th, 2020. Among 102 passengers on a Boeing 737-900 aircraft …

… Stephan, Christoph a ; Wolf, Timo b ; Goetsch, Udo d ; Bellinger, Oswald d ; Nisius,
Gabriele a ; Oremek, Gerhard c ; Rakus, Zbigniew b ; Gottschalk, René d ; Stark, Sonja d ; …

The IgG1 monoclonal antibody (mAb) bamlanivimab (LY-CoV555) prevents viral attachment
and entry into human cells by blocking attachment to the ACE2 receptor. However, whether …

Whether monoclonal antibodies are able to neutralize severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2) variants of concern has been investigated using pseudoviruses. …

Omicron is the evolutionarily most distinct SARS-CoV-2 variant (VOC) to date and displays
multiple amino acid alterations located in neutralizing antibody sites of the spike (S) protein. …

In a patient transferred from Togo to Cologne, Germany, Lassa fever was diagnosed 12
days post mortem. Sixty-two contacts in Cologne were categorised according to the level of …